These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30726245)

  • 21. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population.
    Aoki T; Yamamoto Y; Ikenoue T; Onishi Y; Fukuhara S
    Sci Rep; 2018 Feb; 8(1):3806. PubMed ID: 29491441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimorbidity patterns in patients with heart failure: an observational Spanish study based on electronic health records.
    Gimeno-Miguel A; Gracia Gutiérrez A; Poblador-Plou B; Coscollar-Santaliestra C; Pérez-Calvo JI; Divo MJ; Calderón-Larrañaga A; Prados-Torres A; Ruiz-Laiglesia FJ
    BMJ Open; 2019 Dec; 9(12):e033174. PubMed ID: 31874886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-drug therapy in chronic condition multimorbidity: a systematic review.
    Doos L; Roberts EO; Corp N; Kadam UT
    Fam Pract; 2014 Dec; 31(6):654-63. PubMed ID: 25192902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care.
    Stafford G; Villén N; Roso-Llorach A; Troncoso-Mariño A; Monteagudo M; Violán C
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort.
    Ioakeim-Skoufa I; Clerencia-Sierra M; Moreno-Juste A; Elías de Molins Peña C; Poblador-Plou B; Aza-Pascual-Salcedo M; González-Rubio F; Prados-Torres A; Gimeno-Miguel A
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in polypharmacy over 12 years and changes in its social gradients in South Korea.
    Baek YH; Shin JY
    PLoS One; 2018; 13(9):e0204018. PubMed ID: 30226885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and outcomes of polypharmacy in chronic obstructive pulmonary disease patients: A cross-sectional study from Crete, Greece.
    Ierodiakonou D; Theodorou E; Sifaki-Pistolla D; Bouloukaki I; Antonopoulou M; Poulorinakis I; Tsakountakis N; Voltiraki F; Chliveros K; Tsiligianni I
    Clin Respir J; 2021 Dec; 15(12):1310-1319. PubMed ID: 34425633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of methods for identifying multimorbidity patterns: a study of 'real-world' data.
    Roso-Llorach A; Violán C; Foguet-Boreu Q; Rodriguez-Blanco T; Pons-Vigués M; Pujol-Ribera E; Valderas JM
    BMJ Open; 2018 Mar; 8(3):e018986. PubMed ID: 29572393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.
    Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
    Drugs Aging; 2009; 26(6):493-503. PubMed ID: 19591524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.
    Young EH; Pan S; Yap AG; Reveles KR; Bhakta K
    PLoS One; 2021; 16(8):e0255642. PubMed ID: 34343225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health professional perspectives on the management of multimorbidity and polypharmacy for older patients in Australia.
    Mc Namara KP; Breken BD; Alzubaidi HT; Bell JS; Dunbar JA; Walker C; Hernan A
    Age Ageing; 2017 Mar; 46(2):291-299. PubMed ID: 27836856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial.
    Adam L; Moutzouri E; Baumgartner C; Loewe AL; Feller M; M'Rabet-Bensalah K; Schwab N; Hossmann S; Schneider C; Jegerlehner S; Floriani C; Limacher A; Jungo KT; Huibers CJA; Streit S; Schwenkglenks M; Spruit M; Van Dorland A; Donzé J; Kearney PM; Jüni P; Aujesky D; Jansen P; Boland B; Dalleur O; Byrne S; Knol W; Spinewine A; O'Mahony D; Trelle S; Rodondi N
    BMJ Open; 2019 Jun; 9(6):e026769. PubMed ID: 31164366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis.
    Guisado-Clavero M; Roso-Llorach A; López-Jimenez T; Pons-Vigués M; Foguet-Boreu Q; Muñoz MA; Violán C
    BMC Geriatr; 2018 Jan; 18(1):16. PubMed ID: 29338690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polypharmacy and Multimorbidity Among Medicaid Enrollees: A Multistate Analysis.
    Feng X; Tan X; Riley B; Zheng T; Bias T; Sambamoorthi U
    Popul Health Manag; 2018 Apr; 21(2):123-129. PubMed ID: 28683221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study.
    Niksic M; Redondo-Sanchez D; Chang YL; Rodriguez-Barranco M; Exposito-Hernandez J; Marcos-Gragera R; Oliva-Poch E; Bosch-Barrera J; Sanchez MJ; Luque-Fernandez MA
    BMC Cancer; 2021 Sep; 21(1):1048. PubMed ID: 34556072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of social determinants of health on quality of life in patients with multimorbidity and polypharmacy.
    Ruiz-Baena JM; Moreno-Juste A; Poblador-Plou B; Castillo-Jimena M; Calderón-Larrañaga A; Lozano-Hernández C; Gimeno-Miguel A; Gimeno-Feliú LA;
    PLoS One; 2024; 19(9):e0297702. PubMed ID: 39325736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing.
    Walsh KA; O'Regan NA; Byrne S; Browne J; Meagher DJ; Timmons S
    Int Psychogeriatr; 2016 Nov; 28(11):1807-1820. PubMed ID: 27527842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival in relation to multimorbidity patterns in older adults in primary care in Barcelona, Spain (2010-2014): a longitudinal study based on electronic health records.
    Ibarra-Castillo C; Guisado-Clavero M; Violan-Fors C; Pons-Vigués M; López-Jiménez T; Roso-Llorach A;
    J Epidemiol Community Health; 2018 Mar; 72(3):185-192. PubMed ID: 29330165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.